+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Resorbable Vascular Scaffold Market - Global Forecast 2026-2032- Product Image
Resorbable Vascular Scaffold Market - Global Forecast 2026-2032- Product Image
New

Resorbable Vascular Scaffold Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 194 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6012364
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The resorbable vascular scaffold market is undergoing transformative change as material innovation, supply chain advancement, and evolving regulatory frameworks redefine both opportunity and risk for senior healthcare and device executives. Rapid shifts in clinical preferences and procurement landscapes mean leaders need not just data, but targeted insights to inform sustainable investment and operational strategies.

Market Snapshot: Resorbable Vascular Scaffold Market Overview

The resorbable vascular scaffold market expanded from USD 464.65 million in 2025 to USD 500.68 million in 2026 and is forecast to reach USD 779.98 million by 2032, representing a CAGR of 7.68%. This upward trajectory is fueled by increased clinical demand for vascular devices that promote natural vessel healing and integration, as well as significant innovation in scaffold design and streamlined manufacturing processes. The combination of clinical adoption and technological progress has fundamentally reshaped both supply and demand dynamics across regional and global markets.

Scope & Segmentation

  • Therapeutic Indications: Solutions target coronary artery disease—including acute coronary syndrome and stable angina—as well as peripheral arterial disease, supporting diverse patient profiles and procedure types.
  • Material Platforms: Main device constructions utilize magnesium alloys, recognized for their strength and biocompatibility; and polylactic acid-based scaffolds, preferred for controllable degradation characteristics.
  • Care Settings: Adoption spans hospitals, cardiac centers, and ambulatory surgical centers—each influenced by procedural workflow and tailored reimbursement models.
  • Device Sizing: Market offerings account for scaffold diameters both below and above 3 millimeters, customizing fit for variable lesion anatomies. Length options include under 18mm, between 18 and 28mm, and over 28mm for precise procedural needs.
  • Regional Coverage: The Americas, Europe, Middle East & Africa, and Asia-Pacific markets each require tailored go-to-market and clinical strategies, reflecting regulatory diversity and local partnership needs. Regional growth in Asia-Pacific is notably influenced by harmonized regulation and strategic alliances.

Key Takeaways for Senior Decision-Makers

  • Enhanced scaffold reliability and performance stem from advancements in magnesium alloy and polylactic materials, elevating the clinical appeal of new-generation devices.
  • Contemporary clinical protocols emphasize precise patient selection, as well as tailored implantation techniques designed specifically for resorbable scaffolds to optimize procedural success and minimize complication rates.
  • Industry leaders are intensifying collaboration with contract manufacturing organizations and regional suppliers, streamlining scale-up for new launches and optimizing regulatory approvals across markets.
  • Integration of advanced manufacturing technologies, such as additive processes and higher-level quality controls, is strengthening supply chain flexibility and enabling broader adoption across multiple care settings.
  • Payer and provider focus is shifting toward products demonstrating patient-centered clinical benefits and clear cost-effectiveness, supporting broader acceptance under value-based care models.

Tariff Impact

Recent tariff policy changes in the United States have prompted vascular scaffold manufacturers to diversify sourcing strategies and consider nearshoring to mitigate risks linked to raw material pricing and supply fluctuations. These shifts bring added scrutiny to capital investment decisions for regional production capabilities and increase the importance of robust, long-term supplier agreements. Hospital procurement teams are adapting their product evaluation protocols in response to both variable pricing and stricter requirements for country of origin traceability and documentation.

Methodology & Data Sources

This report applies a multi-method research framework combining structured interviews with experienced cardiologists, vascular specialists, procurement professionals, and device engineers. Findings have been validated through in-depth literature review, detailed assessment of regulatory submissions, and comprehensive analysis of supply chain exposures. Input from independent sector experts strengthens the reliability and actionability of all insights presented.

Why This Report Matters

  • Gives senior executives a clear view of the critical factors driving market and clinical adoption of resorbable vascular scaffolds, highlighting the convergence of innovation, reimbursement, and regulatory context.
  • Supports supply chain and procurement leaders with strategic guidance on managing tariff-related and operational challenges in alignment with evolving material and technology benchmarks.
  • Provides a foundation for aligning product and market entry strategies to regional requirements, clinical indications, and targeted patient populations.

Conclusion

Strengthening the alignment between material innovation, robust clinical validation, and supply chain agility is essential for sustained leadership in the resorbable vascular scaffold market. Stakeholders prepared to collaborate across the value chain will be positioned to convert technological progress into reliable outcomes for patients and businesses alike.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Resorbable Vascular Scaffold Market, by Indication
8.1. Coronary Artery Disease
8.1.1. Acute Coronary Syndrome
8.1.2. Stable Angina
8.2. Peripheral Arterial Disease
8.2.1. Claudication
8.2.2. Critical Limb Ischemia
9. Resorbable Vascular Scaffold Market, by Material
9.1. Magnesium
9.2. Polylactic Acid
10. Resorbable Vascular Scaffold Market, by Scaffold Diameter
10.1. Less Than 3 Millimeter
10.2. Three Millimeter And Above
11. Resorbable Vascular Scaffold Market, by Scaffold Length
11.1. Eighteen To Twenty Eight Millimeter
11.2. Greater Than Twenty Eight Millimeter
11.3. Less Than Eighteen Millimeter
12. Resorbable Vascular Scaffold Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Cardiac Centers
12.3. Hospitals
13. Resorbable Vascular Scaffold Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Resorbable Vascular Scaffold Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Resorbable Vascular Scaffold Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Resorbable Vascular Scaffold Market
17. China Resorbable Vascular Scaffold Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Biotronik SE & Co. KG
18.7. Boston Scientific Corporation
18.8. Cardionovum GmbH
18.9. Elixir Medical Corporation
18.10. Meril Life Sciences Private Limited
18.11. MicroPort Scientific Corporation
18.12. Shandong Huaan Biotechnology Co., Ltd.
18.13. Terumo Corporation
18.14. Xeltis AG
18.15. Zorion Medical
List of Figures
FIGURE 1. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STABLE ANGINA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STABLE ANGINA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CLAUDICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CLAUDICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CLAUDICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MAGNESIUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MAGNESIUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MAGNESIUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYLACTIC ACID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYLACTIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY LESS THAN 3 MILLIMETER, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY LESS THAN 3 MILLIMETER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY LESS THAN 3 MILLIMETER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY THREE MILLIMETER AND ABOVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY THREE MILLIMETER AND ABOVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY THREE MILLIMETER AND ABOVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY EIGHTEEN TO TWENTY EIGHT MILLIMETER, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY EIGHTEEN TO TWENTY EIGHT MILLIMETER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY EIGHTEEN TO TWENTY EIGHT MILLIMETER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GREATER THAN TWENTY EIGHT MILLIMETER, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GREATER THAN TWENTY EIGHT MILLIMETER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GREATER THAN TWENTY EIGHT MILLIMETER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 59. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2032 (USD MILLION)
TABLE 61. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
TABLE 62. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 66. NORTH AMERICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 68. NORTH AMERICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. LATIN AMERICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 76. LATIN AMERICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2032 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2032 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 90. EUROPE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. EUROPE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 92. EUROPE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2032 (USD MILLION)
TABLE 93. EUROPE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
TABLE 94. EUROPE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 95. EUROPE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2032 (USD MILLION)
TABLE 96. EUROPE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2032 (USD MILLION)
TABLE 97. EUROPE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 103. MIDDLE EAST RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2032 (USD MILLION)
TABLE 105. MIDDLE EAST RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 106. AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 108. AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2032 (USD MILLION)
TABLE 109. AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
TABLE 110. AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 111. AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2032 (USD MILLION)
TABLE 112. AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2032 (USD MILLION)
TABLE 113. AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. ASEAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. ASEAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 125. ASEAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2032 (USD MILLION)
TABLE 126. ASEAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
TABLE 127. ASEAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 128. ASEAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2032 (USD MILLION)
TABLE 129. ASEAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2032 (USD MILLION)
TABLE 130. ASEAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. GCC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GCC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 133. GCC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2032 (USD MILLION)
TABLE 134. GCC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
TABLE 135. GCC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 136. GCC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2032 (USD MILLION)
TABLE 137. GCC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2032 (USD MILLION)
TABLE 138. GCC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 141. EUROPEAN UNION RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. BRICS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. BRICS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 149. BRICS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2032 (USD MILLION)
TABLE 150. BRICS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
TABLE 151. BRICS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 152. BRICS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2032 (USD MILLION)
TABLE 153. BRICS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2032 (USD MILLION)
TABLE 154. BRICS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. G7 RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. G7 RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 157. G7 RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2032 (USD MILLION)
TABLE 158. G7 RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
TABLE 159. G7 RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 160. G7 RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2032 (USD MILLION)
TABLE 161. G7 RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2032 (USD MILLION)
TABLE 162. G7 RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. NATO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. NATO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 165. NATO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2032 (USD MILLION)
TABLE 166. NATO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
TABLE 167. NATO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 168. NATO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2032 (USD MILLION)
TABLE 169. NATO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2032 (USD MILLION)
TABLE 170. NATO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 177. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2032 (USD MILLION)
TABLE 179. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 181. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 182. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2032 (USD MILLION)
TABLE 183. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
TABLE 184. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
TABLE 185. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2032 (USD MILLION)
TABLE 186. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2032 (USD MILLION)
TABLE 187. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Resorbable Vascular Scaffold market report include:
  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Elixir Medical Corporation
  • Meril Life Sciences Private Limited
  • MicroPort Scientific Corporation
  • Shandong Huaan Biotechnology Co., Ltd.
  • Terumo Corporation
  • Xeltis AG
  • Zorion Medical

Table Information

Report AttributeDetails
No. of Pages194
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 500.68 Million
Forecasted Market Value ( USD ) by 2032 $ 779.98 Million
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Bioresorbable Vascular Scaffold Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Bioresorbable Vascular Scaffold Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 195 Pages
  • Global
From
Bioresorbable Vascular Scaffolds - Global Strategic Business Report - Product Image

Bioresorbable Vascular Scaffolds - Global Strategic Business Report

  • Report
  • 265 Pages
  • Global
From
Mg Alloy Vascular Scaffold Market - Global Forecast 2026-2032 - Product Image

Mg Alloy Vascular Scaffold Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
PLA Vascular Scaffold Market - Global Forecast 2026-2032 - Product Image

PLA Vascular Scaffold Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Peripheral Vascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Peripheral Vascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From

About the Market

The Resorbable Vascular Scaffold (RVS) market is a segment of the Cardiovascular Devices industry. RVS are medical devices used to treat coronary artery disease, a condition caused by the narrowing of the arteries that supply blood to the heart. RVS are designed to be implanted in the artery and gradually dissolve over time, allowing the artery to return to its natural state. This technology has been shown to reduce the risk of restenosis, a condition in which the artery becomes narrowed again after treatment. RVS are becoming increasingly popular due to their ability to reduce the risk of restenosis and the fact that they do not require a second procedure to remove the device. Additionally, RVS are less invasive than traditional stents, which require a larger incision and a longer recovery time. Some companies in the RVS market include Abbott, Biotronik, Boston Scientific, Medtronic, and Terumo. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.